BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1966555)

  • 1. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure.
    Alexiewicz JM; Klinger M; Pitts TO; Gaciong Z; Linker-Israeli M; Massry SG
    J Am Soc Nephrol; 1990 Sep; 1(3):236-44. PubMed ID: 1966555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure.
    Gaciong Z; Alexiewicz JM; Linker-Israeli M; Shulman IA; Pitts TO; Massry SG
    Kidney Int; 1991 Jul; 40(1):96-106. PubMed ID: 1921161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.
    Alexiewicz JM; Gaciong Z; Klinger M; Linker-Israeli M; Pitts TO; Massry SG
    Am J Nephrol; 1990; 10(6):495-501. PubMed ID: 2075908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone inhibits immunoglobulin production without affecting cell growth in human B cells.
    Jiang Y; Yoshida A; Ishioka C; Kimata H; Mikawa H
    Clin Immunol Immunopathol; 1992 Dec; 65(3):286-93. PubMed ID: 1451331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in B-cell function and metabolism in uremia: role of parathyroid hormone.
    Smogorzewski M; Massry SG
    Kidney Int Suppl; 2001 Feb; 78():S186-9. PubMed ID: 11169008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired in vivo antibody production in CRF rats: role of secondary hyperparathyroidism.
    Gaciong Z; Alexiewicz JM; Massry SG
    Kidney Int; 1991 Nov; 40(5):862-7. PubMed ID: 1762290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of parathyroid hormone on human T cell activation.
    Klinger M; Alexiewicz JM; Linker-Israeli M; Pitts TO; Gaciong Z; Fadda GZ; Massry SG
    Kidney Int; 1990 Jun; 37(6):1543-51. PubMed ID: 1972968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
    Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary hyperparathyroidism and the immune system in chronic renal failure.
    Massry SG; Alexiewicz JM; Gaciong Z; Klinger M
    Semin Nephrol; 1991 Mar; 11(2):186-201. PubMed ID: 1852069
    [No Abstract]   [Full Text] [Related]  

  • 10. Nifedipine reverses the abnormalities in [Ca2+]i and proliferation of B cells from dialysis patients.
    Alexiewicz JM; Smogorzewski M; Akmal M; Klin M; Massry SG
    Kidney Int; 1996 Oct; 50(4):1249-54. PubMed ID: 8887284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.
    Bover J; Jara A; Trinidad P; Rodriguez M; Felsenfeld AJ
    Bone; 1999 Sep; 25(3):279-85. PubMed ID: 10495131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal function on renal responsiveness to parathyroid hormone in primary hyperparathyroidism and chronic renal failure.
    Lewin IG; Hendy GN; Papapoulos SE; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1985 Feb; 15(1):38-44. PubMed ID: 2985400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular proliferation and secretion in secondary hyperparathyroidism during renal failure.
    Fujisaki T; Hida M; Hiraga S; Osamura RY
    Nephron; 1997; 77(1):68-75. PubMed ID: 9380241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes.
    Massry SG; Schaefer RM; Teschner M; Roeder M; Zull JF; Heidland A
    Kidney Int; 1989 Nov; 36(5):883-90. PubMed ID: 2615195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone and B cell function in dialysis patients and experimental chronic renal failure.
    Alexiewicz J; Gaciong Z; Massry SG
    Miner Electrolyte Metab; 1995; 21(1-3):45-9. PubMed ID: 7565461
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.
    Rodriguez M; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parathyroid hormone on random migration of human polymorphonuclear leukocytes.
    Doherty CC; LaBelle P; Collins JF; Brautbar N; Massry SG
    Am J Nephrol; 1988; 8(3):212-9. PubMed ID: 2853573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.